This move is archived. Current quotes and coverage live on the stock page.
Get APTX alerts:

Apotex Health Corp's stock has seen a notable increase of 3.15% in the last trading session, reflecting positive investor sentiment.
On June 11, 2026, Apotex Health Corp (APTX.TO) celebrated its listing on the Toronto Stock Exchange (TSX), marking a significant milestone for the company. This event seems to have boosted investor confidence, leading to a 3.15% rise in its stock price, closing at CA$28.85. As the largest Canadian-based pharmaceutical company, Apotex is well-positioned to leverage its extensive portfolio of generic and innovative health products.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
Market cap
$7.68B
52W high
$40.18
52W low
$26.05
1W change
+2.01%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 25.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+25.2% Upside
Current Price
C$33.02
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
29.8%
Annualized
90-Day Vol
47.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$39.48
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$35.05 | C$31.62 – C$38.84 |
| 60 trading days | C$37.19 | C$32.16 – C$43.02 |
| 90 trading days | C$39.48 | C$33.03 – C$47.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are responding positively to Apotex's market debut, highlighting the company's potential for growth in the pharmaceutical sector.
3.15% Increase in Stock Price
Apotex Health Corp's stock rose by 3.15% in the last trading session, reflecting strong market interest following its recent listing.
Bull case
With a market cap of CA$6.4 billion and a diverse product lineup, Apotex is set for continued growth. The company's focus on providing affordable healthcare solutions could attract more investors looking for stability in the health sector.
Bear case
Even with the positive movement, investors should stay cautious. The pharmaceutical industry is highly competitive and faces regulatory scrutiny, which could affect Apotex's growth path.
Advertisement
Market Debut Boosts Investor Confidence
The recent listing of Apotex Health Corp on the TSX has generated significant buzz among investors. This milestone not only enhances the company's visibility but also underscores its commitment to providing innovative healthcare solutions. As investor confidence grows, the stock's performance reflects a positive outlook for the future.
Company Overview and Growth Potential
As the largest Canadian-based pharmaceutical company, Apotex has a robust portfolio that includes generic, biosimilar, and innovative branded pharmaceuticals. With a market cap of CA$6.4 billion, the company is strategically positioned to capitalize on the increasing demand for affordable healthcare solutions. Investors are closely watching how Apotex navigates the competitive landscape of the pharmaceutical industry.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


